Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa
Authors:
- Anja ReuterARAnja Reuter
- Buci BekoBBBuci Beko
- Boniwe MemaniBMBoniwe Memani
- Jennifer FurinJFJennifer Furin
- Johnny DanielsJDJohnny Daniels
- Erickmar RodriguezERErickmar Rodriguez
- Hermann ReuterHRHermann Reuter
- Lize WeichLWLize Weich
- Petros IsaakidisPIPetros Isaakidis
- Erin von der HeydenEHErin von der Heyden
- Yulene KockYKYulene Kock
- Erika Mohr-HollandEMErika Mohr-Holland
Open Access
- 31 January 2022
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (2) , 21
Abstract
Substance use (SU) is associated with poor rifampicin-resistant tuberculosis (RR-TB) treatment outcomes. In 2017, a SBIRT (SU screening-brief intervention-referral to treatment) was integrated into routine RR-TB care in Khayelitsha, South Africa. This was a retrospective study of persons with RR-TB who were screened for SU between 1 July 2018 and 30 September 2020 using the ASSIST (Alcohol, Smoking and Substance Involvement Screening Test). Here we describe outcomes from this program. Persons scoring moderate/high risk received a brief intervention and referral to treatment. Overall, 333 persons were initiated on RR-TB treatment; 38% (n = 128) were screened for SU. Of those, 88% (n = 113/128) reported SU; 65% (n = 83/128) had moderate/high risk SU. Eighty percent (n = 103/128) reported alcohol use, of whom 52% (n = 54/103) reported moderate/high risk alcohol use. Seventy-seven persons were screened for SU within ≤2 months of RR-TB treatment initiation, of whom 69%, 12%, and 12% had outcomes of treatment success, loss to follow-up and death, respectively. Outcomes did not differ between persons with no/low risk and moderate/high risk SU or based on the receipt of naltrexone (p > 0.05). SU was common among persons with RR-TB; there is a need for interventions to address this co-morbidity as part of “person-centered care”. Integrated, holistic care is needed at the community level to address unique challenges of persons with RR-TB and SU.Keywords
This publication has 22 references indexed in Scilit:
- Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatmentInternational Journal of Mycobacteriology, 2016
- Integrating Community Health Workers Into Primary Care to Support Behavioral Health Service DeliveryJournal of Ambulatory Care Management, 2015
- Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South AfricaThe International Journal of Tuberculosis and Lung Disease, 2014
- Alcohol, Hospital Discharge, and Socioeconomic Risk Factors for Default from Multidrug Resistant Tuberculosis Treatment in Rural South Africa: A Retrospective Cohort StudyPLOS ONE, 2013
- ‘I cry every day’: experiences of patients co‐infected with HIV and multidrug‐resistant tuberculosisTropical Medicine & International Health, 2013
- Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South AfricaPLOS ONE, 2013
- Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, RussiaAddiction, 2013
- Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South AfricaPLOS ONE, 2013
- Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance2007
- Opioid antagonists for alcohol dependence2005